# CelluJuve® for the Treatment of Moderate to Severe NLFs

> **NCT07545980** · NA · NOT_YET_RECRUITING · sponsor: **Spiderwort Biotechnologies Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Nasolabial Fold Wrinkles

## Interventions

- **DEVICE:** CelluJuve®

## Key facts

- **NCT ID:** NCT07545980
- **Lead sponsor:** Spiderwort Biotechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-29
- **Primary completion:** 2026-10-15
- **Final completion:** 2028-07-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07545980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07545980, "CelluJuve® for the Treatment of Moderate to Severe NLFs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07545980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*